Mitigating Risk in the Business of Drug Development

The biotech and pharma industry landscape is evolving at an incredible pace. For small and emerging biopharma companies, the key to business success extends well beyond the quality of your molecule. To realize the full potential of your discovery, you need partners who can help you anticipate and overcome financial, strategic and operational challenges throughout your development journey.

Join Thermo Fisher Scientific Senior Vice President and President, Pharma Services, Michel Lagarde and Jorge Valera, CEO of VelocityTX, for an intimate and deep discussion about common challenges faced by small and emerging biopharma and the strategies to overcome them.